Navigation Links
Solta Medical Reports First Quarter Results
Date:5/1/2012

to non-GAAP net income of $0.7 million, or $0.01 per diluted share for same period last year.

Solta Medical's GAAP results for the first quarter include a $4.7 million charge for a fair value reassessment of the expected earn out payments associated with the acquisition of Liposonix, $2.1 million of non-cash amortization and other acquisition related charges, and $1.1 milllion of non-cash stock based compensation charges. The Company provides non-GAAP financial measures that exclude these charges and expenses. A reconciliation of GAAP to non-GAAP results is provided in the tables included in this release.

Financial Outlook for 2012The company updated its financial outlook for 2012 as follows:

  • Revenue for the full year 2012 is now expected to be in the range of $140 million to $143 million representing year-over-year revenue growth of 20% to 23% driven by sales of the second generation Liposonix system.
  • Non-GAAP gross margin is estimated to be in the range of 63% to 66% for the full year 2012. Non-GAAP gross margin excludes non-cash amortization charges, non-cash stock based compensation charges, severance costs, and acquisition related adjustments. Non-GAAP gross margin for the first quarter was approximately 68%.
  • Positive non-GAAP EBITDA for every quarter and for the full-year 2012. Non-GAAP EBITDA excludes non-cash amortization charges, non-cash stock based compensation charges, severance costs, and acquisition related adjustments. Positive non-GAAP EBITDA for the first quarter was $550,000.
  • Non-GAAP PresentationTo supplement the condensed consolidated financial information presented on a GAAP basis, management has provided non-GAAP gross margin, non-GAAP operating income (loss), non-GAAP EBITDA, non-GAAP net income (loss) and non-GAAP earnings (loss) per share measures that exclude the impact of acquisition related adjustments, severance costs, acquisition related costs, and stock-based compensation expen
    '/>"/>

    SOURCE Solta Medical, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Solta Medical to Report First Quarter 2012 Results Release and Host Conference Call on May 1
    2. Solta Medical Provides Update on Liposonix Launch
    3. Solta Medical Reports FDA Clearance Received for Second Generation LipoSonix® System
    4. Solta Medical Reports Second Quarter Results
    5. Solta Medical Reports First Quarter Results
    6. Solta Medical to Present at the JMP Securities Research Conference
    7. Solta Medical Announces First Quarter 2011 Results Release and Conference Call
    8. Solta Medical Reports Fourth Quarter and Full Year 2010 Results
    9. Solta Medical Announces Full Year and Fourth Quarter 2010 Results Release and Conference Call
    10. Solta Medical, Inc. Appoints Thomas J. Yorkey, Ph.D. to Vice President of Research & Development
    11. Solta Medical Ships One Millionth Tip for Thermage and Fraxel Devices
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)...  The Partnership to Fight Chronic Disease (PFCD) released a public opinion ... a new study analyzing the impact of increased cost sharing on ... working to educate policy makers and the public on the costs ... on how the Iowa healthcare exchange could ...
    (Date:1/23/2015)... , Jan. 23, 2015  Northwest Biotherapeutics, Inc. (NASDAQ: ... immune therapies for operable and inoperable solid tumor cancers, announced ... the 7 th Annual Phacilitate Immunotherapy Forum in ... at Phacilitate will take place on January 26 at 10:30 ...
    (Date:1/23/2015)... More than a third of reproductive-aged women enrolled in Medicaid, ... filled a prescription for an opioid pain medication each year ... and Mortality Weekly Report (MMWR). Opioids are ... severe pain.  They are also found in some prescription cough ...
    Breaking Medicine Technology:New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3
    ... MOUNTAIN VIEW, Calif., March 7, 2011 IRIDEX Corporation (Nasdaq: ... to make an investor presentation at the ROTH 23rd Annual ... pm Pacific Time.  The conference is being held March 13-16 ... The presentation will be accessible by live webcast ...
    ... Grifols, a global healthcare company and biopharmaceutical manufacturer ... established an Expert Advisory Council in Transfusion Medicine drawing ... from across the globe.  The role of the Expert ... to Grifols, own transfusion medicine research and development activities. ...
    Cached Medicine Technology:Grifols Establishes Expert Advisory Council in Transfusion Medicine 2Grifols Establishes Expert Advisory Council in Transfusion Medicine 3
    (Date:1/22/2015)... 20 years, Dr. David Cruz of Cruz Chiropractic Care ... about every type of injury that can result from car accidents ... years, the team at Doctors on Liens has been ... With the combined breadth of experience between the two, ...
    (Date:1/22/2015)... Joan Lunden, award-winning American journalist, beloved television ... 32nd Annual Miami Breast Cancer Conference planned ... (PER®) , shares that “a fast-growing, virulent” cancer in ... had not followed up her clean mammogram with an ...
    (Date:1/22/2015)... Calif. (PRWEB) January 22, 2015 ... Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were ... their leadership in advancing biotechnology, biomedical science, medical ... and Olsen each received the “2014 Life Sciences ...
    (Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative and ... to treat specific body parts and muscle groups. , ... to use patented cold therapy machine with the innovative IsoTube ... muscle injuries. IsoComforter has become the industry leader in ...
    (Date:1/22/2015)... January 22, 2015 Payday lending practices ... communities and cause financial distress to the states that ... at Howard University’s Center on Race and Wealth. , ... economic activity, payday loans at the same time substantially ...
    Breaking Medicine News(10 mins):Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
    ... D.C. Areas of the brain responsible for ... patients who exercised following a medication holiday, say ... say the changes indicate brain functioning is more ... the brains resources is devoted to processing bothersome ...
    ... SUNDAY, Nov. 13 (HealthDay News) -- When added to standard ... people with "acute coronary syndrome" lower their risk of death, ... Acute coronary syndrome is an umbrella term that includes people ... finding "opens up a new area for treating this very ...
    ... study has identified a novel gene mutation that appears ... cases of malignant melanoma, the most deadly form of ... gene encoding MITF, a transcription factor that induces the ... in which melanoma originates. While previous research has ...
    ... A wearable defibrillator can prevent sudden death in people ... the American Heart Association,s Scientific Sessions 2011. , Wearable ... at higher risk for sudden cardiac arrest, including those ... a condition that prevents or delays them from receiving ...
    ... women with breast cancer have taken the drug tamoxifen, only ... tumors do not respond to the treatment at all, or ... at the University of California, San Francisco (UCSF) have discovered ... way to defeat it. On Sunday, Nov. 13, ...
    ... (HealthDay News) -- All U.S. children between the ages of ... to new guidelines endorsed by the nation,s leading group of ... guidelines that suggest such testing be done only for children ... blood cholesterol, which is one of the major risk factors ...
    Cached Medicine News:Health News:Improved memory efficiency seen after aerobic exercise in fibromyalgia patients 2Health News:Blood Thinner Xarelto Shows Promise for Heart Patients 2Health News:Blood Thinner Xarelto Shows Promise for Heart Patients 3Health News:Blood Thinner Xarelto Shows Promise for Heart Patients 4Health News:Newly identified gene mutation adds to melanoma risk 2Health News:Newly identified gene mutation adds to melanoma risk 3Health News:Wearable defibrillator can prevent death in people with arrhythmias 2Health News:Tamoxifen resistance -- and how to defeat it 2Health News:Tamoxifen resistance -- and how to defeat it 3Health News:Tamoxifen resistance -- and how to defeat it 4Health News:New Guidelines Urge Cholesterol Check for All Kids Ages 9 to 11 2Health News:New Guidelines Urge Cholesterol Check for All Kids Ages 9 to 11 3Health News:New Guidelines Urge Cholesterol Check for All Kids Ages 9 to 11 4
    200 L, Bulk, yellow Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less....
    For restriction digests, immuno-precipitations, enzyme assays, TLC spotting and others...
    The Finntip 20 is suitable for applications requiring high precision and volumes of 0.2-20 ul. The tips are provided in convenient racks of 384 tips....
    10 L, Bulk Recommended for 2, 5, 10 L pipettes....
    Medicine Products: